In this report, our team research the USA Clinical Next-Generation Sequencing market by type, application, region and manufacturer (2014-2020) and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Clinical Next-Generation Sequencing for these regions, from 2014 to 2026 (forecast), including
Northeast
Midwest
South
West
USA Clinical Next-Generation Sequencing market competition by top manufacturers/players, with Clinical Next-Generation Sequencing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Roche
Pacific Bioscience
Agilent Technologies
Macrogen
Oxford Nanopore
Foundation Medicine
Life technologies
Exosome Diagnostics
CLC Bio
Paradigm
Partek
GnuBIO
Caris Life Sciences
Others
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Targeted Sequencing
Exome Sequencing
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Clinical Next-Generation Sequencing for each application, including
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Clinical Next-Generation Sequencing Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Targeted Sequencing Market Performance (Volume)
2.1.2 Exome Sequencing Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Targeted Sequencing Market Performance (Value)
2.2.2 Exome Sequencing Market Performance (Value)
3 Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.1.1 Hospitals and Clinics Market Performance (Volume)
3.1.2 Biopharma Companies Market Performance (Volume)
3.1.3 Academic and Research Organizations Market Performance (Volume)
3.1.4 Others Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Profiles
4.1.2 Thermo Fisher Scientific Product Information
4.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Performance
4.1.4 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Development and Market Status
4.2 PerkinElmer
4.2.1 PerkinElmer Profiles
4.2.2 PerkinElmer Product Information
4.2.3 PerkinElmer Clinical Next-Generation Sequencing Business Performance
4.2.4 PerkinElmer Clinical Next-Generation Sequencing Business Development and Market Status
4.3 Illumina
4.3.1 Illumina Profiles
4.3.2 Illumina Product Information
4.3.3 Illumina Clinical Next-Generation Sequencing Business Performance
4.3.4 Illumina Clinical Next-Generation Sequencing Business Development and Market Status
4.4 Beckman Coulter
4.4.1 Beckman Coulter Profiles
4.4.2 Beckman Coulter Product Information
4.4.3 Beckman Coulter Clinical Next-Generation Sequencing Business Performance
4.4.4 Beckman Coulter Clinical Next-Generation Sequencing Business Development and Market Status
4.5 GATC Biotech
4.5.1 GATC Biotech Profiles
4.5.2 GATC Biotech Product Information
4.5.3 GATC Biotech Clinical Next-Generation Sequencing Business Performance
4.5.4 GATC Biotech Clinical Next-Generation Sequencing Business Development and Market Status
4.6 Qiagen
4.6.1 Qiagen Profiles
4.6.2 Qiagen Product Information
4.6.3 Qiagen Clinical Next-Generation Sequencing Business Performance
4.6.4 Qiagen Clinical Next-Generation Sequencing Business Development and Market Status
4.7 Roche
4.7.1 Roche Profiles
4.7.2 Roche Product Information
4.7.3 Roche Clinical Next-Generation Sequencing Business Performance
4.7.4 Roche Clinical Next-Generation Sequencing Business Development and Market Status
4.8 Pacific Bioscience
4.8.1 Pacific Bioscience Profiles
4.8.2 Pacific Bioscience Product Information
4.8.3 Pacific Bioscience Clinical Next-Generation Sequencing Business Performance
4.8.4 Pacific Bioscience Clinical Next-Generation Sequencing Business Development and Market Status
4.9 Agilent Technologies
4.9.1 Agilent Technologies Profiles
4.9.2 Agilent Technologies Product Information
4.9.3 Agilent Technologies Clinical Next-Generation Sequencing Business Performance
4.9.4 Agilent Technologies Clinical Next-Generation Sequencing Business Development and Market Status
4.10 Macrogen
4.10.1 Macrogen Profiles
4.10.2 Macrogen Product Information
4.10.3 Macrogen Clinical Next-Generation Sequencing Business Performance
4.10.4 Macrogen Clinical Next-Generation Sequencing Business Development and Market Status
4.11 Oxford Nanopore
4.12 Foundation Medicine
4.13 Life technologies
4.14 Exosome Diagnostics
4.15 CLC Bio
4.16 Paradigm
4.17 Partek
4.18 GnuBIO
4.19 Caris Life Sciences
4.20 Macrogen
5 Market Performance for Manufacturers
5.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Manufacturers (2014-2020)
5.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
5.4 USA Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Northeast Market Performance for Manufacturers
6.1.1 Northeast Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
6.1.2 Northeast Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
6.1.3 Northeast Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 Northeast Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 Midwest Market Performance for Manufacturers
6.2.1 Midwest Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
6.2.2 Midwest Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
6.2.3 Midwest Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 Midwest Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 South Market Performance for Manufacturers
6.3.1 South Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
6.3.2 South Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
6.3.3 South Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 South Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 West Market Performance for Manufacturers
6.4.1 West Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
6.4.2 West Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
6.4.3 West Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 West Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
7 USA Clinical Next-Generation Sequencing Market Performance (Sales Point)
7.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Regions (2014-2020)
7.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Regions (2014-2020)
7.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) by Regions (2014-2020)
7.4 USA Clinical Next-Generation Sequencing Gross Margin by Regions (2014-2020)
8 Development Trend for Regions (Sales Point)
8.1 USA Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
8.2 Northeast Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
8.3 Midwest Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
8.4 South Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
8.5 West Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospitals and Clinics Industry
11.2 Biopharma Companies Industry
11.3 Academic and Research Organizations Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 USA Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 USA Clinical Next-Generation Sequencing Sales (K Units) and Growth Rate 2021-2026
12.1.3 Northeast Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 Midwest Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 South Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 West Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales (K Units), Revenue (M USD) by Types 2021-2026
12.3.1 Overall Market Performance
12.3.2 Targeted Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3.3 Exome Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.4 Sales by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 Hospitals and Clinics Sales and and Growth Rate 2021-2026
12.4.3 Biopharma Companies Sales and and Growth Rate 2021-2026
12.4.4 Academic and Research Organizations Sales and and Growth Rate 2021-2026
12.4.5 Others Sales and and Growth Rate 2021-2026
12.5 Price (USD/Unit) and Gross Profit
12.5.1 USA Clinical Next-Generation Sequencing Price (USD/Unit) Trend 2021-2026
12.5.2 USA Clinical Next-Generation Sequencing Gross Profit Trend 2021-2026
13 Conclusion